Zacks Investment Research on MSN
JAZZ or ACAD: Which is the better value stock right now?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Jazz ...
Acadia plans re-examination after CHMP rejects Rett syndrome drug trofinetide in the EU, delays potential approval despite ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is among the 10 Fastest Growing Mid Cap Stocks to Buy Now. ACADIA Pharmaceuticals ...
Shares of Acadia Pharmaceuticals ACAD lost 9.9% on Wednesday after the company announced a disappointing update from a late-stage study of its investigational candidate, intranasal carbetocin (ACP-101 ...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...
ACADIA Pharmaceuticals Inc. Annual cash flow by MarketWatch. View ACAD net cash flow, operating cash flow, operating expenses and cash dividends.
We believe that the stock price of ACADIA Pharmaceuticals (NASDAQ: ACAD), a biopharmaceutical company focused on neuroscience drugs, looks undervalued at current levels of around $22. ACAD stock is ...
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Acadia Pharmaceuticals (ACAD) and Techne (TECH). But which of these two stocks is more attractive to ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results